Navigation Links
National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients
Date:1/16/2009

MADISON, Wis. Jan. 12, 2009 The 2009 winners of the National Lung Cancer Partnership/LUNGevity Foundation Research Grants are Prasad Adusumilli, M.D. and Lee Goodglick, Ph.D. The $100,000 grants will fund the scientist's research on visceral pleural invasion and the role of estrogen in lung cancer tumors, respectively.

Dr. Adusumilli, a general thoracic surgeon specializing in lung cancer at Memorial Sloan-Kettering Cancer Center in New York, was awarded the grant focused on basic research for his proposed study of Visceral Pleural Invasion, a condition that affects one in four early stage lung cancer patients in which their cancer spreads to the membrane covering the lungs surface and is associated with poorer treatment outcomes.

Using a mouse model, Dr. Adusumilli's will use genetic engineering to program immune cells to target and suppress tumor cells on the lung membrane.

Dr. Goodglick of the David Geffen School of Medicine at the University of California, Los Angeles was awarded the grant for research in the area of sex differences in lung cancer. His research will focus on estrogen, which many lung cancers either make or are responsive to, similarly to breast cancer. Aromatase-inhibitors, drugs which turn off the enzyme aromatase which can cause some cancers to grow and have long been used in breast cancer treatment, will be studied in a pre-clinical trial to determine their effectiveness in treating lung cancer. Additional research will use new technology to address other ways that estrogen may affect lung cancer in order to identify future therapies.

"Only by continuing to fund this type of lung cancer research can we keep the momentum towards better treatments for patients," Dr. Joan Schiller, president of the National Lung Cancer Partnership and chief of hematology/oncology of the University of Texas Southwestern Medical Center said. "Supporting the work of scientists like Drs. Adusumilli and Goodglick is critical to our continued battle against the world's number 1 cancer killer."


'/>"/>

Contact: Colleen O'Donnell
codonnell@pcipr.com
312-558-1770
National Lung Cancer Partnership
Source:Eurekalert

Related biology news :

1. Landmark national study reveals significance of green practices in attractions industry
2. International experts weigh-in on harmful algal blooms
3. International copper industry defines role in the fight against hospital infections
4. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
5. International public-private partnership offers new paradigm for medicinal chemistry
6. Childrens National convenes first childhood obesity symposium
7. The International Society for Stem Cell Research releases new guidelines
8. Endangered sawfish focus of national collection and recovery efforts
9. New national park protects worlds rarest gorilla
10. Lab test for allergy scoops national
11. Halas wins high-profile national security award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:4/21/2017)... ... April 21, 2017 , ... ... to nourishing a range of emerging bio and technology start-ups, is hosting “Celebration ... 2017. This double event will start with libations and networking at 3:30 p.m. ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... new webinar will explore challenging patient cases when screening for direct oral anticoagulant. ... may be a need for bridging parental anticoagulation especially for those at high ...
(Date:4/20/2017)... 2017  Eli Lilly and Company (NYSE: ... for the prevention of migraine at the American Academy ... April 22-28, 2017, in Boston . ... AAN, including safety and patient outcomes data for galcanezumab ... reduction in monthly migraine headache days among patients with ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
Breaking Biology Technology: